№ 6 / 2017 / 97-104

INTERACTION BETWEEN MAIN FACTORS OF METABOLIC SYNDROME PATHOGENESIS AND ITS COMPONENTS IN MEN

Author: Lutov Yu.V.¹, Selyatitskaya V.G², Vasileva O.V.³, Pinkhasov B.B.⁴

Abstract

Objective: to study the dependence of the parameters characterizing the metabolic syndrome (MS) and its components on the availability and various combinations of the main factors of its pathogenesis in men. Material and methods. A survey of 239 men working at an industrial enterprise was carried out. The criteria of the Consensus of international experts in the fields of cardiology and endocrinology (2009) were used to verify the MS and its main components; the index of insulin resistance HOMA-IR was calculated; the dysfunction of visceral adipose tissue was determined by calculating the index of visceral obesity; testosterone deficiency was detected at testosterone blood levels no more than 12 nmol/L. Results and discussion. The frequency of occurrence and expression degree of the parameters characterizing the MS and its components are directly proportional to the number of its pathogenesis factors simultaneously detected in the men surveyed. Thereat the pathogenetic role of testosterone deficiency was manifested only in the late stages of MS development when connected to the combination of insulin resistance with dysfunction of visceral adipose tissue.

Key words

men, metabolic syndrome, insulin resistance, dysfunction of visceral adipose tissue, testosterone deficiency

References

Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C. et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation taskforce on epidemiology and prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity // Circulation. 2009. 120. 1640-1645.

Amato M.C., Giordano C. Visceral adiposity index: an indicator of adipose tissue dysfunction // Int. J. Endocrinol. 2014. ID 730827.

Amato M.C., Giordano C., Galia M., Criscimanna A., Vitabile S., Midiri M., Galluzzo A. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk // Diabetes Care. 2010. 33. (4). 920-922.

Amato M.C., Pizzolanti G., Torregrossa V., Misiano G., Milano S., Giordano C. Visceral adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes // PLoS One. 2014. 9.(3). ID e91969.

Beltran-Sanchez H., Harhay M.O., Harhay M.M., Mc Elligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010 // J. Am. Coll. Cardiol. 2013. 62. (8). 697–703.

Constantinopoulos P., Michalaki M., Kottorou A., Habeos I., Psyrogiannis A., Kalfarentzos F., Kyriazopoulou V. Cortisol in tissue and systemic level as a contributing factor to the development of metabolic syndrome in severely obese patients // Eur. J. Endocrinol. 2015. 172. (1). 69-78.

Du T., Sun X., Huo R., Yu X. Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009 // Int. J. Obesity. 2014. 38. 840-847.

Du T., Yuan G., Zhang M., Zhou X., Sun X., Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance // Cardiovasc. Diabetol. 2014. 13. ID 146.

Ebrahimi F., Christ-Crain M. Metabolic syndrome and hypogonadism – two peas in a pod // Swiss Med. Wkly. 2016. 146. ID w14283.

Grundy S.M. Metabolic syndrome update // Trends Cardiovasc. Med. 2016. 26. (4). 364-373.

Hatzimouratidis K., Hatzichristou D. Testosterone and erectile function: an unresolved enigma // Eur. Urol. 2007. 52. (1). 26-28.

Kang Y.M., Jung C.H., Cho Y.K., Jang J.E., Hwang J.Y., Kim E.H., Lee W.J., Park J.Y., Kim H.K. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype // PLoS One. 2017. 12.(6). e0179635. 14 p.

Lorenzo C., Williams K., Hunt K.J., Haffner S.M. The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes // Diabetes Care. 2007. 30. (1). 8–13.

Matthews D., Hosker J., Rudenski A. Homeostatis model assessment: insulin resistance and b-cell functionn from fasting plasma glucose and insulin concentrations in man // Diabetologia. 1985. 28. 412-419.

Moretti C., Lanzolla G., Moretti M., Gnessi L., Carmina E. Androgens and hypertension in men and women: a unifying view // Curr. Hypertens. Rep. 2017. 19. ID 44.

Novikova E., Selyatitskaya V., Mitrofanov I., Pinkhasov B., Karapetyan A. Association of erectile dysfunction and hypogonadism with metabolic syndrome in men with lower urinary tract symptoms of younger and older age groups // Adv. Sex. Med. 2014. 4. 55-64.

Paniagua J.A. Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome // World J. Diabetes. 2016. 7. (19). 483-514.

Pinkhasov B.B., Lutov Yu.V., Deev D.A., Selyatitskaya V.G. Stratification of the risk and severity of metabolic syndrome in patients in need of therapeutic treatment // Klinicheskaya meditsina = Clinical Medicine. 2017. 95. (5). 412-418. [In Russian].

Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an Endocrine Society clinical practice guideline // J. Clin. Endocrinol. Metab. 2008. 93. (10). 3671–3689.

Reaven G.M. The individual components of metabolic syndrome: is there a raison d’etre? // J. Am. Nutr. 2007. 26.(3). 191-195.

Research letter. Visceral adipose tissue dysfunction and mortality among a population-based sample of males and females // Diabetes Metab. 2016. 42. 382-385.

Roitberg G.E, Dorosh J.V, Sharkhun O.O. The influence of insulin resistance on the formation and progression of metabolic syndrome components (the results of a five-year study) // Ratsional’naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2015. 11. (2). 132-138. [In Russian].

Ruan H., Dong L.Q. Adiponectin signaling and function in insulin target tissues // J. Mol. Cell. Biol. 2016. 8. (2). 101-109.

Sveklina T.S., Talantzeva M.S., Barsukov A.V. The metabolic syndrome and inflammation: actual issues of pathogenesis // Klinicheskaya laboratornaya diagnostika = Clinical laboratory diagnostics. 2013. (3). 7-10. [In Russian].

Tsanava I.A., Shronova L.A., Verbovoy A.F. Metabolic syndrome and cardiovascular diseases // Russkiy meditsinskiy zhurnal = Russian medical journal. 2017. 25. (11). 785-789. [In Russian].

Varlamov O. Western-style diet, sex steroids and metabolism // Biochim. Biophys. Acta. 2017. 1863. 1147-1155.

Wang N., Zhai H., Han B., Li Q., Chen Y., Xia F., Lin D., Lu Y. Visceral fat dysfunction is positively associated with hypogonadism in Chinese men // Scientific Reports. 2016. 6. ID 19844.

Xiao J., Shen C., Chu M.J., Gao Y.X., Xu G.F., Huang J.P., Xu Q.Q., Cai H. Physical activity and sedentary behavior associated with components of metabolic syndrome among people in rural China // PLoS One. 2016. 11.(1). ID e0147062.

About Authors (Correspondence):

Lutov Yu.V. – candidate of medical sciences, senior researcher of the laboratory of endocrinology, e-mail: yvl1308@mail.ru

Full Text

snmzh_6-2017_lutov_i_dr.pdf

Received: 10/01/2018